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Abstract  23 
Membrane bound Acyltransferase_3 (AT3) domain-containing proteins are implicated in a wide 24 
range of carbohydrate O-acyl modifications but their mechanism of action is largely unknown. O-25 
antigen acetylation by AT3 domain-containing acetyltransferases of Salmonella spp. can generate a 26 
specific immune response upon infection and can influence bacteriophage interactions. This study 27 
integrates in situ and in vitro functional analysis of two of these proteins, OafA and OafB (formerly 28 
& ?'ƚƌ )ǁŚŝĐŚĚŝƐƉůĂǇĂŶ  ‘d ?-^'E,ĨƵƐĞĚ ?ĚŽŵĂŝŶĂƌĐŚŝƚĞĐƚƵƌĞǁŚĞƌĞĂŶ ŝŶƚĞŐƌĂůŵĞŵďƌĂŶĞ AT3 29 
domain is fused to an extra-cytoplasmic SGNH domain. An in silico-inspired mutagenesis approach of 30 
the AT3 domain identified seven residues which are fundamental for the mechanism of action of 31 
OafA, with a particularly conserved motif in TMH1 indicating a potential acyl donor interaction site. 32 
Genetic and in vitro evidence demonstrates that the SGNH domain is both necessary and sufficient 33 
for lipopolysaccharide acetylation.  The structure of the periplasmic SGNH domain of OafB identified 34 
features not previously reported for SGNH proteins. In particular, the periplasmic portion of the 35 
inter-domain linking region is structured. Significantly, this region constrains acceptor substrate 36 
specificity, apparently by limiting access to the active site.  Co-evolution analysis of the two domains 37 
suggests possible inter-domain interactions. Combining these data we propose a refined model of 38 
the AT3-SGNH proteins, with structurally constrained orientations of the two domains. These 39 
findings enhance our understanding of how cells can transfer acyl groups from the cytoplasm to 40 
specific extracellular carbohydrates.  41 
Importance 42 
Acyltransferase-3 (AT3) domain-containing membrane proteins are involved in O-acetylation of a 43 
diverse range of carbohydrates across all domains of life. In bacteria they are essential in processes 44 
including symbiosis, resistance to antimicrobials, and biosynthesis of antibiotics. Their mechanism of 45 
action, however, is poorly characterised. We analysed two acetyltransferases as models for this 46 
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important family of membrane proteins, that modify carbohydrates on the surface of the pathogen 47 
Salmonella enterica, affecting immunogenicity, virulence and bacteriophage resistance. We show 48 
that when these AT3 domains are fused to a periplasmic partner domain, both domains are required 49 
for substrate acetylation. The data shows conserved elements in the AT3 domain and unique 50 
structural features of the periplasmic domain.  Our data provides a working model to probe the 51 
mechanism and function of the diverse and important members of the widespread AT3 protein 52 
family, which are required for biologically significant modifications of cell-surface carbohydrates.  53 
 54 
Introduction  55 
Salmonella infections are a considerable public health burden in both developing and developed 56 
countries. Salmonella enterica subspecies enterica serovar Typhimurium (STM) is estimated to cause 57 
more than 150,000 human deaths from gastroenteritis each year (1, 2). A sublineage of this serovar 58 
is the dominant cause of invasive non-Typhoidal Salmonella (iNTS) bloodstream infections in Africa 59 
(3). The Typhi serovar of this subspecies is the major cause of typhoid fever, resulting in over 60 
200,000 deaths annually (2, 4). In the US, there are over 10,000 cases annually of these serovars 61 
combined (5, 6). 62 
Cell surface lipopolysaccharide (LPS) is an important virulence factor. The O-antigen, the most distal 63 
and variable portion of LPS, is composed of repeating oligosaccharide units whose composition and 64 
structure varies between species and, in the case of Salmonella spp., between serovars. Modification 65 
of the O-antigen by alteration of sugar linkages or addition of moieties such as glucose or acetate (7, 66 
8) can influence immunogenicity, virulence, and confer resistance to lytic phage infection (9 ?12). 67 
Carbohydrates on the bacterial cell surface are frequently O-acetylated by acyltransferase proteins 68 
which contain a 10 transmembrane helix (TMH) Acyltransferase_3 (AT3, IPR002656, PF01757; also 69 
4 
 
known as Acyltransferase_3/Putative Acetyl-CoA Transporter, TC 9.B.97). This family of proteins is 70 
widespread in eukaryotes and prokaryotes and is involved in a range of acylation modifications. 71 
Examples of AT3-containing acetyltransferases from prokaryotes include those mediating 72 
peptidoglycan acetylation contributing to lysozyme resistance (13, 14), modification of root 73 
nodulation factors to initiate symbioses (15), and O-antigen acetylation (9, 16, 17). Despite the 74 
involvement of AT3-containing proteins in a wide range of reactions, their mechanism and structure 75 
are poorly characterised.  76 
Among bacterial AT3 carbohydrate acetyltransferases, there are two known domain architectures; 77 
proteins consisting of an AT3 domain only (AT3-only) and an N-terminal AT3 domain linked to an 78 
extra-cytoplasmic domain, commonly an SGNH domain (AT3-SGNH fused). The SGNH domain is 79 
fused through addition of an 11th TMH and linking region. Oac (in Shigella spp.) is an example of an 80 
AT3-only protein that is essential for O-antigen acetylation (18) whereas OatA, the O-81 
acetyltransferase of peptidoglycan in Staphylococcus spp., is an example of an AT3-SGNH fused 82 
protein (14). SGNH domains (InterPro IPR036514) are a large and diverse family of small catalytic 83 
domains of around 200 amino acids, originally characterised as a subgroup of the GDSL hydrolase 84 
family by their particular invariant residues, Ser, Gly, Asn, His - hence SGNH  ? which occur in four 85 
blocks of conserved sequence (19, 20). Members of this family that are active against carbohydrates 86 
are also classified as CE3 family proteins in CAZy (21).  Subsequently, many more proteins have been 87 
found to belong to this diverse family and they no longer fully adhere to the original paradigm of 88 
SGNH. However, most members typically contain a catalytic triad of Ser, His, Asp and oxyanion hole 89 
residues within the four blocks of conserved sequence (22). It is not clear how the AT3 and SGNH 90 
domains function together in AT3-SGNH fused carbohydrate acetyltransferases, nor how the AT3-91 
only proteins function independently of a linked periplasmic domain. 92 
In Salmonella spp. there are two defined O-antigen acetyltransferases OafA and OafB (9, 10, 17, 23). 93 
Slauch et al. determined that the integral membrane protein OafA from STM (17), acetylates the 2-94 
5 
 
hydroxyl group on the abequose moiety of the O-antigen unique to this serovar (24). This results in 95 
acquisition of the O:5 serotype (defined by the Kauffmann White Lee Minor scheme) (25, 26) which 96 
is required for production of protective antibodies against STM infection (24, 27). Multiple  97 
Salmonella serovars have a rhamnose moiety in the O-antigen that can be acetylated at the 2- and 3- 98 
hydroxyl groups by F2GtrC proteins (9, 10, 23). As it is clear that F2GtrC is an acetyltransferase with 99 
no functional relationship to the GtrABC glycosylating proteins, we propose to rename this and 100 
orthologous rhamnose acetyltransferases as OafB. The name reflects the protein architecture (O-101 
antigen acetyltransferase fused B), similar to that we suggest for OafA (O-antigen acetyltransferase 102 
fused A). 103 
In this work, using in situ and in vitro functional analysis of OafA and OafB O-antigen 104 
acetyltransferases, we address the following key questions to further our understanding of the 105 
mechanism of acetyl transport and transfer in AT3-SGNH fused acetyltransferases. (I) Are there 106 
essential residues in the membrane-bound AT3 domain that can give clues to their role in acetyl 107 
transfer? (II) Can we obtain insight into the architecture of these proteins by elucidating the 108 
structure of the SGNH domain and its N-terminal extension? (III) What is the function of the SGNH 109 
domain and can it function independently of the AT3 domain?  110 
 111 
Results  112 
In silico analysis identifies conserved features in the integral membrane domains of 113 
bacterial AT3 acetyltransferases  114 
The STM O-antigen acetyltransferases OafA (17) and OafB (23) (formerly F2GtrC) are both predicted 115 
by InterPro to contain an N-terminal AT3 domain (IPR002656, PF01757)  fused to an SGNH domain 116 
(IPR013830, PF14606 or PF13472) (28, 29) (Fig. 1A). The AT3 domain has 10 TMH and an additional 117 
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11th helix that is presumably required to localise the fused SGNH domain in the periplasm (Fig. 1A) 118 
(30); this prediction is supported by experimental topology analysis of OafB (9) and consistent with 119 
topology analysis of Oac (31) , a comparison enabled by our detailed alignments (see below).  120 
Reinforcing the widespread functions of these understudied proteins in bacteria, we identified in the 121 
literature 30 bacterial AT3 domain-containing proteins, with experimentally confirmed carbohydrate 122 
acetyltransferase activity (9, 14 ?17, 32 ?55). Of these 30 proteins, 19 contain just the AT3 domain, 123 
while 11, including OafA and OafB, have the fused AT3-SGNH architecture (SI Appendix, Table S1). 124 
Previous work showed that in OafA and OafB, the SGNH domain is essential for acetyltransferase 125 
activity (9, 56) and thus, we propose the following working model for the mechanism of action (Fig. 126 
1B). In AT3-SGNH proteins, the AT3 domain passes an acetyl group from an unidentified donor in the 127 
cytoplasm to the periplasmic face of the inner membrane. This acetyl group is then transferred to 128 
the SGNH domain, which catalyses specific carbohydrate O-acetylation (Fig. 1B). To test this model, 129 
we first determined whether residues conserved between AT3-only and AT3-SGNH 130 
acetyltransferases are important for acetyltransferase activity.   131 
Alignments of the 30 characterised AT3 acetyltransferases along with a S. enterica serovar Paratyphi 132 
A (SPA) OafB homologue revealed that only 4 amino acids are invariant across all 31 proteins, 133 
OafAH25, OafAF41, OafAG46 and OafAG202 (Fig. 2A, SI Appendix, Fig. S1). OafAF41 and OafAG46 belong to 134 
the FFXISG motif previously identified in un-fused AT3 O-antigen acetyltransferases (SI Appendix, Fig. 135 
S1) (31). Two conserved residues are predicted in TMH1, separated by 10 amino acids, in an R/K-X10-136 
H motif (Fig. 2A, SI Appendix, Fig. S1). A previously identified RXXR motif (OafAR69,R72) in loop 2-3 is 137 
essential for activity in Shigella flexneri Oac (OacR73, R75)(57), and OafB (OafBR71, R73) (9). This motif is 138 
highly (but not absolutely) conserved across the 31 analysed acetyltransferases. 139 
We next examined features unique to the AT3 domains of AT3-SGNH fused acetyltransferases; these 140 
11 sequences derive from diverse Gram positive and Gram negative bacteria (Fig. 2B, SI Appendix, 141 
Table S1). The most striking shared feature of AT3-SGNH fused proteins is the highly conserved GG-142 
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F/Y-XGV-D/P/V motif located at the periplasmic side of TMH2 (OafAG33-D39), which replaces a longer 143 
and more divergent loop region between TMH1-2 in the non-fused AT3 proteins.  Further conserved 144 
residues are seen in the periplasmic loop between TMH3-4, including OafAS112, OafAN113 and OafAY122. 145 
Together these observations suggest shared key residues in both AT3-only and AT3-SGNH fused 146 
proteins and possible adaption of AT3 domains in AT3-SGNH fused acetyltransferases towards their 147 
function together with the fused SGNH domain.  148 
Site-directed mutagenesis combined with in situ functional analysis of OafA 149 
identifies functional residues within the AT3 domain  150 
To determine the functional importance of conserved residues in OafASTM, we developed an in situ 151 
functional assay using a double antibody LPS immunoblot. The assay quantifies both the level of 152 
acetylated abequose (O:5) and the amount of LPS based on the O-antigen core (Fig. 3). His-tagged 153 
OafA, or mutated versions thereof, were expressed in trans in a strain that lacks all O-antigen 154 
modification genes including oafA (strain 293) (Methods, SI Appendix, Table S2). Levels of abequose 155 
acetylation in these strains was determined by LPS immunoblot from the signal obtained with 156 
serotype antibody and protein expression was also confirmed (Fig. 3, SI Appendix, Fig. S2).  We 157 
validated this approach by comparing abequose acetylation by the in trans system, to both 158 
chromosomal His-tagged OafA and wild type OafA.  This showed that despite a higher level of 159 
protein in the in trans system (Fig. 3B), a comparable level of abequose acetylation was obtained in 160 
all strains (Fig. 3A and SI Appendix, Fig. S2).  161 
Twenty positions in the membrane bound domain of OafA were individually engineered to replace 162 
the wild-type amino acid with alanine.  The level of O-antigen acetylation in situ as a result of mutant 163 
protein expression is summarized in Table 1 and Fig. 4, and data are shown in SI Appendix, Fig. S2. 164 
Point mutants that gave <1% O-antigen acetylation signal in relation to wild type were considered to 165 
be inactive and those with <50% O-antigen acetylation signal were considered to have significantly 166 
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reduced activity. For all mutant proteins except G34A there was detectable full-length protein on the 167 
Western blot, sometimes in addition to degradation products (SI Appendix, Fig. S2).  Assay validation 168 
experiments indicate that the levels of full length mutant protein is in excess of wild type levels and 169 
thus should be sufficient to confer detectable abequose O-acetylation.  170 
The arginine and histidine residues in the R/K-X10-H motif (OafAR14 and OafAH25) are essential for 171 
function. These residues are predicted to be on the same surface of the alpha helix with a spacing 172 
ƐŝŵŝůĂƌƚŽƚŚĞƉƌĞĚŝĐƚĞĚĚŝƐƚĂŶĐĞďĞƚǁĞĞŶƚŚĞ ? ?ƉŚŽƐƉŚĂƚĞĂŶĚƚŚĞƚŚŝŽĞƐƚĞƌďŽŶĚŽĨŽŶĞĐŽĞŶǌǇŵĞ173 
A molecule (~19 Å). Thus, we hypothesise these residues provide a potential Acetyl-CoA interaction 174 
site within the AT3 domain. The 100% conserved glycines (OafAG46 and OafAG202) could be replaced 175 
with alanine with no detriment. As expected, both arginines in the TMH3 RXXR motif (OafAR69, R72) (9, 176 
57) were essential for OafA function (Table 1, Fig. 4).  177 
We next examined the unique aspects of the AT3 domains among the AT3-SGNH fused proteins.  Of 178 
the conserved GG-F/Y-XGV-D/P/V motif and flanking residues, mutation of OafAF35 and OafAD39 179 
caused significant reduction and complete loss of OafA activity, respectively. OafAS112A mutation also 180 
caused complete loss of OafA activity (Table 1, Fig. 4). AT3-only acetyltransferases do not contain an 181 
11th TMH but a glutamate residue after the C-terminal end of TMH10 (OafAE325) is invariant across 182 
AT3-SGNH protein sequences; mutation of this residue (OafAE325A) resulted in significant reduction in 183 
OafA activity (Table 1, Fig. 4). Thus, AT3-SGNH-specific conserved residues in the AT3 domain are 184 
inherently involved in the mechanism of action of OafA.  185 
OafBSPA
long
 has an extended SGNH-like fold 186 
To gain an understanding of the mechanism of OafA and OafB both domains must be analysed, thus 187 
in vitro analysis of the SGNH domain was conducted. Structural analysis of the SGNH domains and 188 
periplasmic linking regions of OafA and OafB were used to gain insight into the functional 189 
adaptations of an SGNH domain fused directly to an AT3 domain. We expressed and purified 190 
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residues 366 to 609 from OafA (OafASTM
C-long) and residues 377 to 640 of SPA OafB from (OafBSPA
C-191 
long), which have 31% sequence identity (Fig. 1A). Although OafBSPA has not been experimentally 192 
characterised in the literature, SPA O-antigen rhamnose can be acetylated (58) and OafBSPA has 78% 193 
sequence identity to the experimentally characterised OafBSTM rhamnose acetyltransferase (9).  194 
No diffracting crystals of OafASTM
C-long could be obtained, however, crystals diffracting to 1.1 Å 195 
resolution were obtained for OafBSPA
C-long, with a single molecule in the asymmetric unit. The 196 
structure could not be solved by molecular replacement using a number of known SGNH structures, 197 
but was solved using Fragon (59) with a 14 residue ideal polyalanine ɲ-helix as the search model and 198 
refined to an Rwork/Rfree of 13.6/14.9% (SI Appendix, Table S3).  199 
The core structure of OafBSPA
C-long
 resembles an SGNH domain, with an ɲ ?ɴ ?ɲ ŚǇĚƌŽůĂƐĞ ĨŽůĚ200 
consisting of ĨŝǀĞ ĐĞŶƚƌĂů ɴ-ƐƚƌĂŶĚƐ ƐƵƌƌŽƵŶĚĞĚ ďǇ Ɛŝǆ ɲ-helices (Fig. 5A). Two disulfide bonds are 201 
seen in the structure (Fig. 5A) and were verified using mass spectrometry. The closest structural 202 
homologues to OafBSPA
C-long, as identified by the DALI server, are carbohydrate esterases from 203 
Talaromyces cellulolyticus (5B5S) and Clostridium thermocellum (2VPT); each have an RMSD of 2.5 Å 204 
over 207 and 201 backbone residues, respectively.  205 
The first clear difference between OafBSPA
C-long when compared to its closest structural homologues 206 
and the only other SGNH domain from a fused acyltransferase with a solved crystal structure, OatA-207 
SGNH (5UFY) (60) is that the structure is significantly larger, at ~36k Å3, compared to OatA-SGNH at 208 
~23k Å3 , which is more similar to the size of the two most closely related structures of the 209 
carbohydrate esterases (2VPT is ~26k Å3 and 5B5S is 27k Å3). This additional volume in the fold is 210 
contributed by two separate non-contiguous parts of the structure, the first being helix ɲ8, which 211 
comprises 10% of the SGNH domain volume (Fig. 5). A structure-based alignment of related SGNH 212 
domains indicated that the sequence forming this additional helix is only present in AT3-SGNH 213 
domains involved in acetylation of LPS O-antigens (Fig. 6A, SI Appendix, Fig. S3) and so is missing on 214 
OatA. Secondly, and most significantly the region that connects the end of TM11 and the start of the 215 
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sequence of other known SGNH domains (residues 377-421) is clearly structured and forms a long 216 
extension of the SGNH domain that we now term the SGNH extension (SGNHext). The SGNHext 217 
interacts extensively with the SGNH domain covering 1500 Å2 of the SGNH domain, including 218 
interactions with helix ɲ8; 38 amino acids of the SGNH domain interact with 32 (of 48) residues in 219 
the extension. Removal of the most N-terminal half of the SGNHext (OafASTM
C-short and OafBSPA
C-short 220 
(Fig. 1A)), results in a decrease in melting temperature of 5.7 oC in OafA and 8.9 oC in OafB 221 
suggesting that the SGNHext has a stabilising effect on the SGNH domain (SI Appendix, Fig. S4). These 222 
observations show that OafBSPA
C-long forms an extended SGNH-like fold with an additional helix, and 223 
the periplasmic portion of the linking region is structured and interacts with the SGNH domain.  224 
Catalytic residues of OafBSPA
long
 resemble a typical SGNH domain with an atypical 225 
oxyanion hole 226 
SGNH domains are usually characterised by the presence of four blocks of sequence, containing 227 
conserved residues: block I  ? GDS, block II  ? G, block III  ? GxND and block V  ? DxxH (where x is any 228 
non-proline residue) (22). The structure-based sequence alignment was used to identify conserved 229 
residues in the SGNH domain of fused acyltransferases (Fig. 6B, SI Appendix, Fig. S3). The typical 230 
SGNH catalytic triad, consisting of serine (block I), aspartic acid and histidine (block V), is conserved 231 
in the sequence of both OafA and OafB. In situ functional analysis of catalytic triad mutants OafAS412A 232 
and OafAH590A showed almost complete loss of function, whereas OafAD587A showed reduced activity 233 
(Table 2, Fig. S2).  This is consistent with analyses of typical catalytic triad activity in other SGNH 234 
proteins (61, 62).  235 
While the catalytic triad is conserved in both proteins, the oxyanion hole residues, glycine (block II) 236 
and asparagine (block III), are not (Fig. 6B). Analysis of the structure-based alignment of the block II 237 
region (Fig. 6B, SI Appendix, Fig. S3) reveals the conserved glycine is replaced by an asparagine in 238 
OafB (OafBN459). The structure of OafBSPA
C-long shows OafBN459 to be within hydrogen bonding distance 239 
of a co-crystallised sulfate ion (Fig. 6C) suggesting that OafBN459 could interact with bound substrate 240 
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and participate in oxyanion hole formation. Homology modelling of OafASTM
C-long based on the 241 
structure of OafBSPA
C-long (SI Appendix, Fig. S5) suggests that the OafAS437 side chain or OafAL438 are 242 
most likely to replace the block II glycine in the oxyanion hole. This was supported by the in situ 243 
abequose acetylation assay which shows OafAS437A has significantly reduced activity in comparison to 244 
wild type OafA (Table 2, Fig. S2) consistent with the decrease in activity seen on mutation of the 245 
oxyanion hole residues in other SGNH domains (60, 61, 63).   246 
The GxND motif (block III), where Asn is typically involved in oxyanion hole formation (20), is not 247 
evident in OafA or OafB in the structure-based alignment (Fig. 6B). OafBSPA
C-long contains a GTNG 248 
motif (OafBG502-G505) close to sequence block III (Fig. 6B), but the side chains of these residues are 249 
oriented away from the catalytic triad (Fig. 6C). These observations suggest that, although OafA and 250 
OafB display the typical catalytic triad of an SGNH domain, their oxyanion hole arrangement is 251 
atypical. 252 
The SGNHext confers acceptor specificity 253 
The structured region that extends the OafB SGNH domain (SGNHext) appears to occlude the active 254 
site and results in significantly lower solvent accessible surface area (SASA) of the catalytic triad 255 
residues (40 Å) than in OatA, 2VPT and 5B5S (132 Å, 110 Å and 126 Å, respectively) (Fig. 5C). 256 
Removing the 22 most N-terminal residues from the structure of OafBSPA
C-long (OafBSPA
C-short, Fig. 1A) 257 
increases the SASA of the catalytic triad residues of OafB to 107.9 Å.   258 
To assess the potential consequences of an occluded active site for substrate specificity, assays were 259 
carried out for OafA and OafB containing the full SGNHext (OafASTM
C-long and OafBSPA
C-long) and those 260 
with half the SGNHext (OafASTM
C-short and OafBSPA
C-short) (Fig. 1A). In vitro catalytic activity was first 261 
confirmed for all constructs via their ability to hydrolyse the ester substrate p-nitrophenyl acetate 262 
(pNP-Ac) (SI Appendix, Fig. S6), an assay commonly used to test SGNH domain function (64, 65). This 263 
12 
 
activity suggests that all four proteins are correctly folded and catalytically active regardless of the 264 
presence or absence of the SGNHext residues covering the active site (SI Appendix, Fig. S6). 265 
To assess whether SGNHext affects the in vitro acceptor substrate specificity of OafASTM
C-term and 266 
OafBSPA
C-term proteins, purified proteins were incubated with pNP-Ac (acetyl group donor) and 267 
unmodified STM LPS (Path993, SI Appendix, Table S2) as the acceptor substrate, and O:5 antibodies 268 
were used to probe for O-antigen abequose acetylation. Abequose is the native acceptor sugar for 269 
OafA whereas OafB acetylates rhamnose in situ.  A positive signal for O:5 antibody binding is gained 270 
after incubation with OafASTM
C-long and OafASTM
C-short (Fig. 7). Thus, OafASTM
C-long and OafASTM
C-short are 271 
able to acetylate their native substrate in solution. In contrast, acetylation of the non-native 272 
acceptor substrate by OafB occurs only in the absence of the OafB SGNHext (OafBSPA
C-short) (Fig. 7).  273 
Firstly, these results support our working model that the SGNH domain performs the last step in the 274 
transferase reaction; the transfer of the acetyl moiety to the acceptor carbohydrate. Furthermore, 275 
these results strongly indicate that the acceptor substrate specificity of this SGNH domain is 276 
constrained by the cognate, structured SGNHext.  277 
Evolutionary support for an interaction between the AT3 domain and the SGNH 278 
domain 279 
dŚĞ ĚŝƐĐŽǀĞƌǇ ƚŚĂƚ ƚŚĞ  ‘ůŝŶŬĞƌ ? ƌĞŐion that is present between the more clearly defined AT3 and 280 
SGNH domains is in fact a long structured component of the SGNH domain, means that the SGNH is 281 
much more constrained and proximal to the membrane that initially proposed if this region was a 282 
long flexible linker. The discovery that there are residues in the AT3 loop between TMH3-4 that are 283 
only conserved in the AT3-SGNH fused proteins, suggests potential protein-protein contacts 284 
between the two domains during catalysis. To test this hypothesis we used a co-evolution analysis of 285 
the OafA-B type acetyltransferases to assess whether there was any evidence for correlated changes 286 
in the two domains consistent with a physiological interaction (Fig. S7a). While there are many 287 
correlated changes within the two separate domains, a significant correlated changes was observed 288 
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between residues 95 and 97, located in the periplasmic loop between TMH3-4 of the AT3 domain 289 
(Fig. 8) and residues 542 and 545-546, which form a surface-accessible patch (Fig. S7b) on the 290 
additional helix (ɲ8) of the SGNH domain (Fig. 8). This predicted interaction further informs our 291 
refined topological model of these AT3-SGNH acetyltransferases (Fig. 8).  292 
Discussion 293 
AT3 domain-containing proteins (PF01757) are a ubiquitous family of proteins involved in diverse 294 
carbohydrate modifications across the domains of life. Prokaryotic members of this family play roles 295 
in modification of antibiotics and antitumor drugs, as well as initiation of microbial symbioses with 296 
plants (15, 66, 67)( SI Appendix, Table S1). In bacterial pathogens, such as Salmonella enterica, 297 
Listeria monocytogenes, Haemophilus influenzae and Streptococcus pneumonia, these proteins are 298 
implicated in acetylation of extra-cytoplasmic polysaccharides which can have significance for 299 
interactions with phage and hosts and can affect virulence and antibiotic resistance (24, 32, 36, 38). 300 
The current experimentally characterised AT3 domain-containing carbohydrate O-acetyltransferases 301 
display SGNH-fused or AT3-only domain architecture. Although both AT3 and SGNH domains display 302 
broad substrate ranges in diverse biological systems, the mechanism of action of both SGNH-fused 303 
and AT3-only acetyltransferases is largely unknown.   304 
Previous understanding of AT3-SGNH fused acetyltransferases was obtained by in situ functional 305 
assays, and structure-function assessment of the SGNH domain (9, 17, 60).  Here, expanded 306 
bioinformatic analysis with a set of 30 experimentally characterised bacterial AT3 acetyltransferases, 307 
including AT3-only and AT3-SGNH fused protein sequences, which perform a range of biological 308 
functions (SI Appendix, Table S1), revealed commonalities and key differences.  For example, an R/K-309 
X10-H motif in TMH1 is shared across all the bacterial AT3 acetyltransferases studied (Fig. 2) and is 310 
also highly conserved across all AT3 domain proteins in the Pfam database (29), strongly suggesting 311 
that these are critical catalytic residues relevant to the whole protein family.   312 
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OafAR14 and OafAH25 within this motif were essential for activity (Table 1, Fig. 4) and are predicted to 313 
be at opposite ends, but on the same surface, of the TMH1 helix (arginine towards the cytoplasmic 314 
side) providing a potential interaction site for the proposed acetyl group donor acetyl-CoA. Although 315 
cytoplasmic acetyl-CoA has not been confirmed as the donor for O-antigen acetylation, it occupies a 316 
central role in bacterial metabolism and is a prominent source of acetate in bacterial cells (68, 69). 317 
ƌŐŝŶŝŶĞ ƌĞƐŝĚƵĞƐ ŚĂǀĞƉƌĞǀŝŽƵƐůǇ ďĞĞŶ ŝŵƉůŝĐĂƚĞĚ ŝŶďŝŶĚŝŶŐŽĨ ƚŚĞ  ? ? ƉŚŽƐƉŚĂƚĞŽĨĂĐĞƚǇů-CoA in 318 
other acetyltransferase proteins (70) and conserved histidine residues in the soluble mitochondrial 319 
carnitine O-acyltransferase co-ordinate the thioester bond of acyl-CoA with the carnitine acceptor to 320 
catalyse the acyl-transfer reaction (71). Significantly the equivalent residue was discovered as a 321 
natural histidine to tyrosine point mutation that decreased function of the Streptococcus pneumonia 322 
capsule acetylation protein WcjE in clinical isolates (72). 323 
A similar role for a conserved intermembrane histidine residue has also been suggested for 324 
membrane bound O-acyltransferases containing an MBOAT (IPR004299) rather than AT3 domain 325 
(73). These observations support a role of the R/K-X10H motif in coordinating a cytoplasmic derived 326 
acetyl-CoA molecule within the membrane bound AT3 domain for transfer of the acetyl group to the 327 
SGNH domain, consistent with our model (Fig. 1). AT3 domain-containing proteins are implicated in 328 
transferring a wide range of acyl groups such as succinate, isovalerate, and propionate (67, 74, 75); 329 
these can all be carried by Coenzyme-A.  The proposed mechanism of acetyl donor interaction would 330 
provide a potential conserved mechanism for transfer of any of these acyl substituents, supporting 331 
the idea that the TMH1 arginine and histidine are fundamentally important for the mechanism of all 332 
AT3 domain-containing acyltransferases. 333 
Residues specifically conserved in the AT3 domains of AT3-SGNH fused proteins (OafAF35 and OafAD39 334 
in TMH2 and OafAS112 between TMH3-4) are located towards the periplasmic side of the AT3 domain 335 
(Fig. 2); we suggest these are likely to be important for interaction with the O-antigen substrate or 336 
SGNH domain for acetyl group transfer. In contrast to the essential nature of OafAS112 in the 337 
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periplasmic loop between TMH3-4, no functional residues have been identified in the equivalent 338 
region of S. flexneri Oac (an AT3-only O-antigen acetyltransferase) (57). Conversely, the invariant 339 
glycine residue OafAG46, which was critical in S. flexneri Oac (OacG53) (SI Appendix, Figure S1) (31, 57), 340 
could be replaced by alanine without affecting the function of OafA. These observations imply a 341 
divergence between AT3-only and AT3-SGNH fused proteins. The location of critical residues specific 342 
to the AT3-SGNH fused proteins, further suggest that this divergence occurs at the point of acetyl 343 
group transfer to the acceptor substrate.  344 
This study demonstrates that the SGNH domain of OafA is able to acetylate the abequose of the O-345 
antigen of Salmonella in vitro without the presence of its cognate fused AT3 domain. This supports 346 
the predicted role for SGNH in the final step of acetyl group transfer to the acceptor substrate in 347 
fused acetyltransferases (Fig. 1B). In agreement with this, in the two component PatA/PatB 348 
peptidoglycan acetyltransferase system, PatB, a soluble SGNH protein, is responsible for transfer of 349 
the acetyl group onto the peptidoglycan substrate (62). Moynihan and Clarke et al. hypothesised 350 
that PatA (an MBOAT protein not an AT3) is responsible for transporting the acetyl group across the 351 
membrane where it is transferred to the acceptor by the soluble PatB protein (62). The membrane 352 
bound PatA MBOAT protein in this system is interchangeable with WecH, an AT3-only 353 
acetyltransferase protein (52, 76), giving an example of direct transfer of acetate between a 354 
membrane bound AT3 domain and soluble SGNH domain protein. This supports the mechanistic 355 
model of the AT3 domain delivering the acetyl group to the SGNH domain for transfer onto the 356 
acceptor substrate in AT3-SGNH fused proteins (Fig. 1B).  357 
Our data demonstrated, for the first time in a fused system, the necessity for the fused SGNH 358 
domain in glycan carbohydrate acetylation. However, this poses the conundrum that other closely 359 
related systems, such as OacA from Shigella that O-acetylates rhamnose in the O-antigen (57), lack 360 
either a fused or genetically linked partner SGNH domain. Consequently, either the AT3 domain 361 
functions differently, or there is a currently undiscovered partner protein.  362 
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This study elucidates the structure of the SGNHext in OafBSPA
C-long
 and shows that removal of this 363 
region results in promiscuity of carbohydrate modification in in vitro acetyltransferase reactions (Fig. 364 
7). These findings suggest that the SGNHext plays a role in determining the specificity of the O-365 
antigen residue to be acetylated. Closer examination of the structure reveals that two tyrosines, 366 
Tyr289 and Tyr394, in the SGNHext sit closely to the active site and could potentially be involved in a 367 
mechanism to limit off-target acetylation. Inadvertent acetylation of complex carbohydrates could 368 
potentially have diverse and undesired biological effects due to the variation of cellular processes 369 
that can be affected by acetylation (9, 33, 39, 77 ?79). Whether this also implies that AT3 proteins all 370 
need a partner domain or protein for substrate specific transferase activity remains to be 371 
determined.  372 
Co-evolution analysis predicts interaction between periplasmic loops of the AT3 domain and the 373 
SGNH domain of OafB. This is similar to the arrangement of domains seen in PglB, an oligosaccharide 374 
transferase from Campylobacter lari (80), with 13 TMH and a periplasmic domain. In PglB the 375 
periplasmic domain interacts via periplasmic loops in the transmembrane domain and both domains 376 
are hypothesised to interact with the peptide substrate (80). In our model, the co-evolution analysis 377 
positions the periplasmic loops of the AT3 domain close to ɲ8 helix in the SGNH domain allowing for 378 
a interaction with each other and with the acceptor substrate (Fig. 8).  379 
AT3 domain-containing proteins are involved in the modification of a wide range of polysaccharides 380 
and influence many host-pathogen interactions. These structural and functional insights can be 381 
applied to the well-studied and biotechnologically relevant AT3 proteins, including Nod factor 382 
modifications important for plant microbe symbiosis, and anti-tumour and antibiotic modifying 383 
proteins. Furthermore, this work can inform future studies in eukaryotic systems where AT3 domain-384 
containing proteins are involved in regulation of the lifespan of Caenorhabditis elegans (81) and in 385 
Drosophila development (82).  386 
 387 
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Methods 388 
Bacterial strains, plasmids and culture conditions: 389 
Escherichia coli and STM strains and plasmids are listed in SI Appendix, Table S2. Strains were 390 
cultured in Lennox broth (LB; Fisher Scientific) at 37 °C with appropriate antibiotic selection unless 391 
otherwise stated.  392 
In silico analysis of bacterial AT3 domains to identify conserved residues 393 
A survey of the literature identified 30 experimentally-characterised bacterial carbohydrate 394 
acetyltransferases, these sequences were aligned along with OafB from Salmonella ser. Paratyphi A, 395 
using TCoffee (83). Protein accession numbers are in Fig. S1. TCoffee was also used to align OafASTM, 396 
OafBSTM and OafBSPA protein sequences for direct comparison. 397 
Structure based sequence alignments using PROMALS-3D with default settings were carried out with 398 
the two closest structural homologues identified using the DALI server, and a selection of typical 399 
SGNH domains for which structural information is available: OafBSPA, 1IVN, 4K40, 1DEX, 5UFY, 5B5S 400 
and 2VPT. Five further representative sequences of OafA, OafB, and OatA were included 401 
(A0A0H2WM30, STMMW_03911, Q8ZNJ3, NTHI0512, Q2FV54).  402 
Co-evolution analysis 403 
A multiple sequence alignment of AT3 SGNH domain fused proteins was constructed using the 404 
MUSCLE alignment tool based on 1,188 full length sequences from the UniProt Reference 405 
Proteomes. This alignment was used to construct a profile-HMM to detect further homologues in 406 
the UniProt Reference Proteome set as well as within the MGnify protein sequence set. We required 407 
that all matches to this profile-HMM had a sequence and domain threshold of 27 bits. We also 408 
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required that the sequence matched > 90% of the HMM match states to ensure that homologues 409 
with only one of the two domains were not included in the alignment. 410 
2,713 homologues were identified from the UniProt Reference Proteome set and 9,757 homologues 411 
were identified from the MGnify metagenomics sequences. A large sequence alignment was 412 
constructed using OafB as the master with no indels with all the sequence matches aligned to it 413 
using the hmmalign package and a custom Perl script to format the alignment for contact prediction. 414 
The alignment was submitted to the RaptorX contact prediction server (84). 415 
Molecular Biology 416 
Primers (Sigma-Aldrich) are listed in SI Appendix, Table S2. Mutations were introduced into the OafA 417 
sequence (pMV433 as template), which had been cloned into pBADcLIC using blunt end ligation, 418 
placing the gene under control of an arabinose inducible promoter. Mutants were confirmed by 419 
sequencing. Plasmids were electroporated into STM strain 293 (SI Appendix, Table S2) for analysis of 420 
activity.  421 
All oafASTM and oafBSPA sequences for protein expression were cloned into pETFPP_2 (Technology 422 
Facility, University of York) using in-fusion cloning (Clontech) to add a 3C-protease cleavable N-423 
terminal His-MBP tag. Plasmid pMV433 (SI Appendix, Table S2) was used as the template for creation 424 
of expression plasmids encoding the protein sequence for OafASTM
C-long (residues 366-609) and 425 
OafASTM
C-short (residues 379-609). oafBSPA (A0A0H2WM30) amino acid residues 377 to 640 for 426 
OafBSPA
C-long, was codon-optimised for E. coli and synthesised by Genewiz in a pUC57-Kan vector. This 427 
vector was then used as a template for the sequence encoding OafBSPA
C-short (residues 399-640); see 428 
SI Appendix, Table S2 for primers used.  429 
In situ functional analysis of OafA variants 430 
19 
 
All in situ functional analyses of OafA variants cloned into pBADcLIC were carried out in strain 431 
Path293 (23) (SI Appendix, Table S2). Strains for the in situ functional analysis were cultured at pH 432 
7.0 in 100 mM sodium phosphate-buffered LB at 37 °C in a baffled conical flask with shaking at 200 433 
rpm. Overnight cultures were diluted 100-fold and grown for 16 hr. Samples were normalised to 434 
(OD600) of 3.0 per ml for LPS and protein extraction.  435 
Crude LPS sample preparation  436 
The method was adapted from Davies et al. 2013 (23). 1 ml of OD-normalised (OD600 3.0) overnight 437 
culture was pelleted for 5 min at 16,000xg. Cell pellets were re-suspended in 100 µl LPS sample 438 
buffer (60 mM Tris-HCL, 1mM EDTA, pH 6.8) containing 2% (w/v) SDS then boiled at 100 °C for 5 min. 439 
400 µl of LPS buffer was then used to dilute the solution before RNAse (Roche) and DNAse (Sigma) 440 
treatment Ăƚ ? ?ȗĨŽƌ ? ?ŚŽƵƌƐ ?Samples were then treated with 100 µg proteinase K for 16 hours at 441 
 ? ? ȗ ?  ? ? ? ʅl of crude LPS extracts were run on 1.0 mm Tricine SDS - Poly Acrylamide Gel 442 
Electrophoresis TSDS-PAGE gel for analysis by immunoblotting. 443 
Detection of OafA protein expression for in situ assays 444 
1ml of OD-normalised culture was pelleted for 5 min at 16,000xg. Soluble and insoluble fractions 445 
ǁĞƌĞ ŝƐŽůĂƚĞĚ ĨƌŽŵ ĐĞůů ƉĞůůĞƚƐ ƵƐŝŶŐ ƵŐ ƵƐƚĞƌ ? ƐŽůƵƚŝŽŶ  ?EŽǀĂŐĞŶ ) ĨŽůůŽǁŝŶŐ ŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ446 
instructions for soluble protein extraction. The insoluble pellet was resuspended in 75 µl of sample 447 
buffer (10% (v/v) Glycerol, 1% (w/v) SDS, 10mM Tris-HCL, pH 7.2, 0.06% (w/v) Bromophenol Blue, 3% 448 
(v/v) ɴ-mercaptoethanol), heated to  ? ?ȗĨŽƌ ? ?ŵŝŶĂŶĚĐĞŶƚƌŝĨƵŐĞĚĨŽƌ ? ?ŵŝŶĂƚ ? ? ? ? ? ?ǆŐ ?  ʅl of 449 
insoluble fraction samples were loaded onto a 12% acrylamide 1.0 mm SDS-PAGE gel for analysis.  450 
Immunoblotting 451 
7.5 ʅl of crude LPS extracts were run on 1.0 mm Tricine SDS - Polyacrylamide Gel Electrophoresis 452 
(TSDS-PAGE) gel for analysis by immunoblotting. The TSDS-PAGE-separated LPS samples and SDS-453 
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PAGE separated protein samples were transferred onto Immobilon-P PVDF membrane (Merck-454 
Millipore). For His-tagged protein detection, the primary antibody was Tetra·His Antibody (1:1000) 455 
(Qiagen; in 3% (w/v) BSA TBS) and the secondary antibody was goat anti-mouse IgG-HRP (1:10000) 456 
(Sigma-Aldrich; in 5% (w/v) Milk TBS). The blot was developed using Luminata Classico Western HRP 457 
substrate (Merck-Millipore). For LPS detection O:5 serotyping antibody (1:10000) (Statens Serum 458 
Institute; 40272) and Salmonella core antigen (1:200) (Insight Biotechnology; 5D12A) were used as 459 
the primary antibodies and Goat Anti-Rabbit IgG StarBright Blue700 (1:5000) (Bio-Rad) and Goat 460 
anti-mouse IgG (H+L) DyLight 800 (1:5000) as the respective secondary antibodies. LPS antibodies 461 
were diluted in 5% Milk PBS-T. ChemiDoc MP Imaging System (Bio-Rad )ĂŶĚ/ŵĂŐĞ>Ăď ?  ?ŝŽ-Rad) 462 
were used for image capture and analysis.  The in situ activity of OafA mutant relative to wild type 463 
protein was derived from quantification of the O:5 signal in each lane, standardised to the intensity 464 
of the single O-antigen repeat band for the Salmonella core signal on LPS immunoblots. Assay 465 
validation demonstrated that <1% O:5 signal with respect to wild type was within the background 466 
variation. Variation increased significantly for signal intensities in the higher range, therefore O:5 467 
signal recoded between 50 and 100% relative to wild type was not interpreted further. 468 
Expression and purification of OafASTM
C-term
 and OafBSPA
C-term
  469 
pETFPP_2 vectors containing the inserted OafASTM
C-term
 and OafBSPA
C-term constructs (Fig. 1) were 470 
transformed into Origami (Novagen) E. coli for protein expression. Protein expression was carried 471 
out as described by Gruszka et al. 2015 (85) without the addition of protease inhibitor. The proteins 472 
were purified using immobilised metal affinity chromatography with a HisTrap FF column (GE 473 
Healthcare) utilising a His-tag, followed by size exclusion chromatography after His-tag removal, as 474 
described by Gruszka et al. 2012 (86); purified protein was eluted in 20 mM Tris-HCl pH 7.5, 100 mM 475 
NaCl. 476 
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Melting temperature of OafA and OafB SGNH domains 477 
The melting temperature of SGNH domains was determined using NanoDSF with a protein 478 
concentration of 1 mg/mL in 20 mM TrisHCl pH 7.5, 100 mM NaCl. Proteins were heated from 20 oC 479 
to 95 oC with a heating rate of 2 oC / min. The fluorescence at 330 and 350 nm was measured every 480 
0.05 oC. 481 
In vitro acetylesterase activity assay  482 
The catalytic activity of OafA and OafB C-terminal constructs was confirmed by acetyl esterase 483 
activity using pNP-Ac as a substrate. 100 µl of enzyme solution (10 ʅM OafASTMC-term, 40 ʅM OafBSTMC-484 
term or 0.04 U/ml Acetylxylanesterase) or appropriate control buffers were added to relevant wells of 485 
Ă ? ?ǁĞůůƉůĂƚĞĂŶĚŝŶĐƵďĂƚĞĚĂƚ ? ?ȗĨŽƌ ? ?ŵŝŶƉƌŝŽƌƚ ĂĚĚŝƚŝŽŶŽĨƉEW-Ac. 100 µl of 1 mM pNPA 486 
in the corresponding buffer was then added to matching sample and control wells and immediately 487 
placed into a plaƚĞƌĞĂĚĞƌŝŶĐƵďĂƚĞĚĂƚ ? ?ȗ ?ďƐŽƌďĂŶĐĞĂƚ ? ? ?Ŷŵwas measured at T=0, and then 488 
at 5 min intervals.  489 
In vitro abequose acetyltransferase activity assay 490 
Crude LPS extracted from OafA-negative STM LT2 strain (Path993) was heated at 100°C for 20 min to 491 
inactivate the proteinase K (see above). Heat-treated LPS was mixed 1:1 with KPi buffer (200 mM 492 
NaCl, 50 mM Potassium Phosphate buffer pH 7.8).  10 ʅM OafASTMC-term and 20 ʅM OafBSPAC-term were 493 
incubated at 4 °C in LPS-KPi mixture with 4 mM pNP-Ac dissolved in ethanol (4% (v/v) final 494 
concentration in reaction). Samples of the reaction mix were taken after specified time points and 495 
inactivated by boiling for 10 min. 496 
5 ʅl of LPS reaction samples were loaded onto methanol-activated PVDF membrane using a BioRad 497 
Bio-Dot® microfiltration apparatus. The protocol for LPS detection with O:5 serotyping antibodies 498 
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and Salmonella core antigen was followed as per immunoblotting, following removal of the 499 
membrane from the apparatus after sample loading.  500 
Protein structure analysis 501 
To crystallise OafBSPA
C-long, a hanging-drop vapour diffusion method was used with 20 mg/mL 502 
OafBSPA
C-long in a drop ratio of 1:1 protein:reservoir solution. After incubation for 24 hours at 20oC 503 
crystals grown in 100 mM BisTris pH 5.5, 0.25 M lithium sulfate, 25% PEG 3350 were cryoprotected 504 
by addition of glycerol to a final concentration of 20% and vitrified in liquid nitrogen. 505 
X-ray diffraction data for crystals of OafBSPA
C-long were collected on beamline I04-1 (Diamond Light 506 
Source, UK) at a wavelength of 0.9282 Å using a Pilatus 6M-F detector. Data were integrated with 507 
XDS (87), and scaled and merged with AIMLESS (88) via the Xia2 pipeline (89). Fragon molecular 508 
replacement (59) used Phaser (90) to place an ideal poly-alanine helix of 14 amino acids in length 509 
followed by density modification with ACORN (91). ARP-wARP (92) was used for automated chain 510 
tracing, and the model was  refined using REFMAC5 (93 ?98). Manual manipulation of the model 511 
between refinement cycles was performed using Coot (99, 100). The final model was evaluated using 512 
MolProbity (101) and PDB validate, secondary structure shown in Fig. 5A was annotated using 513 
STRIDE (102).  514 
A homology model of OafASTM
C-long was produced using SwissModel with the structure of OafBSPA
C-long 515 
as a template (103 ?107).  516 
 Data Availability 517 
The atomic coordinates and structure factors have been deposited in the Protein Data Bank (PDB ID 518 
code 6SE1). 519 
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Figure Legends 820 
Fig. 1. OafA and OafB are membrane bound O-acetyltransferases that acetylate the O-antigen of 821 
Salmonella. (A) Schematic representation of OafA and OafB functional (coloured) and 822 
transmembrane (shaded) domains predicted by InterPro and TMHMM respectively. C-term 823 
constructs used for in vitro characterisation are indicated below the protein. (B) Proposed 824 
mechanism of action of O-antigen acetyltransferases during maturation of the LPS in the periplasm 825 
using OafA as an example. AT3 = IPR002656, SGNH= IPR013830  826 
Fig. 2. Conservation in transmembrane domains of experimentally characterised bacterial AT3 827 
carbohydrate acetyltransferases. 100% identical residues are coloured orange, similar residues in > 828 
90% sequences are coloured blue, conserved small hydrophobic residues in transmembrane helices 829 
were not coloured. (A) Conserved residues across all 30 currently known experimentally 830 
characterised proteins and OafBSPA. (B) Conservation in only AT3-SGNH fused proteins in the 831 
alignment. See Table S1 for details of aligned sequences and Fig. S1 for full alignment. 832 
Fig. 3. O-antigen acetylation and OafA expression from plasmid and chromosomally expressed 833 
protein. (A) LPS immunoblot with crude LPS extracts from Salmonella ser. Typhimurium: LT2 basal O-834 
antigen strain expressing OafA from pBADcLIC plasmid (pWT OafA-His), LT2 WT O-antigen strain with 835 
a C-terminal Deca-His tag added to the chromosomal copy of OafA (cWT OafA-His), the same strain 836 
with unmodified OafA (cWT OafA), and the LT2 basal O-antigen strain with an empty pBADcLIC 837 
plasmid (Empty Vector). O:5 antibody binding (Blue) shows abequose acetylation,  Salmonella LPS 838 
core antibody binding (Green) acts as a loading control. (B) Corresponding anti-His Western blot of 839 
insoluble protein fraction for detection of His tagged OafA. Arrow indicates full length OafA protein.   840 
Fig. 4. Summary of mutagenesis analysis of STM OafA. A diamond shape indicates residues that were 841 
mutated, cysteine residues were mutated to serine and all other residues were mutated to alanine. 842 
Results relate to % O-antigen acetylation compared to wild type, mutants that caused loss of protein 843 
expression are diamond shaped but not coloured (G34A).  844 
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Fig. 5. Analysis of the crystal structure of OafBSPA
C-long. (A) Cartoon representation of OafBSPA
C-long with 845 
ŚĞůŝĐĞƐ ĂŶĚ ƐŚĞĞƚƐ ŶƵŵďĞƌĞĚ ? ǁŝƚŚ ƚŚĞ ĂĚĚŝƚŝŽŶĂů ŚĞůŝǆ  ?ɲ ? ) ĐŽůŽƵƌĞĚ ƚĞĂů ĂŶĚ ^'E,-extension 846 
coloured orange. Catalytic residues and disulfide bonds are shown as sticks and labelled. (B) Surface 847 
representation of OafBSPA
C-long with colouring as above and catalytic triad coloured red. (C) Surface 848 
representation of OafBSPA
long, 5UFY, 5B5S and 2VPT. 849 
Fig. 6. Analysis of additional helix and catalytic triad residues (A, B) Structure based sequence 850 
alignments of additional helix (A), indicated by a line above the sequence, and blocks I-V (B) with 851 
residues conserved in > 50% of sequences highlighted blue, catalytic and oxyanion hole residues are 852 
indicated by an arrow. Abbreviations and details of sequences used in methods section. (C) Catalytic 853 
triad and potential oxyanion hole residues shown as sticks, hydrogen bonds to co-crystallised sulfate 854 
ion shown as dashed black lines.  855 
Fig. 7. Effect of SGNHext length on substrate specificity of C-terminal OafA and OafB. Dot blot for 856 
acetylated abequose (ɲO:5  ? blue) on basal Salmonella ser. Typhimurium LPS after incubation with 857 
purified the C-terminal OafA and OafB  and pNPA as an acetyl group donor. 10 ʅM OafA and 20 ʅM 858 
OafB were used in these reactions. ɲCore antibody (green) is used as a loading control. WT 859 
acetylated LPS is used as a positive control. (+) = Active protein, (-) = Heat treated protein. 860 
ZĞƉƌĞƐĞŶƚĂƚŝǀĞŽĨEA? ?ƌĞƉĞĂƚƐ ? ‘->ŽŶŐ ?ĐŽŶƐƚƌƵĐƚƐĐŽŵƉƌŝƐĞƚŚĞ^'E,ĚŽŵĂŝŶǁŝƚŚĨƵůů'^E,ext,  ‘-861 
^ŚŽƌƚ ? ĐŽŶƐƚƌƵĐƚƐ ĐŽŵprise the SGNH domain with fewer SGNHext residues to expose the SGNH 862 
domain active site. See Figure 1 for details of the C-terminal OafA and OafB constructs 863 
Fig. 8. Refined model of AT3-SGNH fused O-antigen acetyltransferases. Periplasmic SGNHext 864 
(Orange) is structured, therefore positioning the SGNH domain (Grey) close to the AT3 domain 865 
(Purple), this orients the additional helix (Teal) in close proximity to the AT3 domain with 866 
interactions between the two domains as proposed by the co-evolution analysis. These observations 867 
result in the current hypothesis: 1) Cytoplasmic acetyl group donor interacts with conserved Arg in 868 
TMH1, the acetyl group is processed and transferred to the periplasmic side of the inner membrane 869 
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and this process involves catalytic His residue of TMH1. 2) Conserved Asp and Ser mediate transfer 870 
of acetate to the SGNH domain. 3) SGNH domain catalyses addition of the acetate to specific O-871 
antigen monosaccharide. The active site of the SGNH domain is highlighted by an asterisk and 872 
interaction site highlighted by a  “+ ?.  873 
Table Legends 874 
Table 1. Summary of site directed mutagenesis analysis of the transmembrane domain of OafA 875 
Table 2. Summary of site directed mutagenesis analysis of the periplasmic domain of OafA 876 
Supplementary Figure Legends 877 
Fig. S1. Alignment of characterised AT3 acetyltransferases. Protein sequences are in the same order 878 
as Table S1 after Salmonella ser. Paratyphi A OafB WP_00400612. SGNH fused acetyltransferases are 879 
indicated by a grey box. Asterisks mark residues selected for mutation from this alignment. 880 
Fig. S2. Functional analysis of OafA membrane bound domain point mutants in situ. Left panel shows 881 
LPS western blot with crude LPS extracts from Salmonella ser. Typhimurium basal O-antigen strain 882 
expressing OafA point mutant variants in (A) the membrane domain and (B) the periplasmic domain. 883 
O:5 antibody binding (Blue) shows abequose acetylation and 884 
 885 
Salmonella LPS core antibody binding (Green) acts as a loading control. Right panel shows 886 
corresponding anti-His western blot for expression of His tagged OafA. Arrow indicates full length 887 
OafA protein. 888 
Fig. S3. Structure based sequence alignment of OafB, OafA and closest structural homologues. 889 
Residues conserved in >50% highlighted blue, catalytic and oxyanion hole residues are indicated by 890 
an arrow. Abbreviations and details of sequences used in methods section. 891 
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Fig. S4. Melting curves of OafASTM
C-long, OafASTM
C-short, OafBSPA
C-long and OafBSPA
C-short, with melting 892 
temperatures of OafASTM
C-long = 63.8 oC, OafASTM
C-short = 58.1 oC, OafBSPA
C-long = 58.9 oC, OafBSPA
C-short = 893 
50.0 oC.  894 
Fig. S5. Comparison of potential oxyanion hole residues in OafA and OafB. A. Homology model of 895 
OafASTM
C-long (yellow) modelled on the structure of OafB (grey, extension in orange and additional 896 
helix in teal). Catalytic triad and potential oxyanion hole residues shown as sticks. Residues indicated 897 
with OafA first. Both Ser 437 side chain and Leu 438 backbone amide are in close proximity to 898 
catalytic triad and active site sulfate. B. Sequence alignment of OafA from Salmonella ser. 899 
Tyhimurium and OafB from Typhimurium and Paratyphi A serovars of Salmonella from OafA residues 900 
410-450. Alignments were carried out using Tcoffee with default settings. Red Box highlights 901 
predicted replacements for catalytic block II glycine. 902 
Fig. S6. In vitro acetyl-esterase activity of C-terminal OafA and OafB assessed by hydrolysis of 903 
pNitrophenyl acetate (pNPA). Solid line = Active protein, dashed line = Heat treated protein. Error 904 
ďĂƌƐA?^D ?EA? ? ?^ŽŵĞĞƌƌŽƌďĂƌƐĂƌĞŽďƐĐƵƌĞĚďǇƉŽŝŶƚŵĂƌŬĞƌƐ ? ‘->ŽŶŐ ?ĐŽŶƐƚƌƵĐƚƐĐŽŵƉƌŝƐĞƚŚĞ905 
^'E,ĚŽŵĂŝŶǁŝƚŚĨƵůů^'E,Ğǆƚ ? ‘-^ŚŽƌƚ ?ĐŽŶƐƚƌƵĐƚƐĐŽŵƉƌŝƐĞƚŚĞ^'E,ĚŽŵĂŝŶǁŝƚŚĨĞǁĞƌ^'E,ext 906 
residues to expose the SGNH domain active site. See Figure 1 for details of the C-terminal OafA and 907 
OafB constructs. 908 
Fig. S7. A) Predicted contact map for OafB based on a correlated mutation analysis using the RaptorX 909 
webserver. The horizontal/vertical line marks residue 377, which forms the boundary at the end of 910 
the AT3 domain. High confidence interactions within the AT3 domain (top left) and the SGNH 911 
domain (bottom right), while a single high scoring interaction between the AT3 (93-97) and SGNH 912 
(524-546) is marked (bottom left). B) Structure of OafBSPA
C-long with residues (542-546) predicted to 913 
interact with the acyltransferase domain coloured blue. The extension is coloured orange, the 914 
additional helix coloured teal, and catalytic triad coloured red. 915 
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Supplementary Table Legends 916 
Table S1. Experimentally characterised bacterial AT3 acetyltransferases 917 
Table S2. Molecular biology materials. Bacterial strains and primers used in this study. Primers for 918 
cloning of OafA and OafB constructs and creation of OafA point mutant variants on the 919 
pBADcLIC_WT-OafA plasmid. ŵƉA?ŵƉŝĐŝůůŝŶ ? ? ?ʅŐ ?ŵů ?<ĂŶA?<ĂŶĂŵǇĐŝŶ ? ?ʅŐ ?ŵů ? 920 
Table S3. X-ray crystallography data and statistics for the structure of OafBSPA
C-long. Values in 921 
parenthesis correspond to the highest resolution shell unless otherwise stated. 922 
 923 
 Table 1. Summary of site directed mutagenesis analysis of the transmembrane domain of OafA 
Mutant 
O:5 signal intensity compared 
to wild type % (± SEM) 
Position Reason for mutation 
R14A      0.07 ± 0.04 
TMH1 
Specifically conserved in AT3-SGNH proteins 
H25A       0.33  ± 0.18 Conserved in TMH1 across all aligned proteins 
S32A    105.25 ± 30.89 
Periplasmic loop 
& TMH2 
XGG-F/Y-XGV-D/P/V-X motif found to be conserved in 
AT3-SGNH fused acyltransferases. In the first 
periplasmic loop between TMH1-2 
G33A    119.17 ± 18.72 
G34A          1.36 ± 0.88* 
F35A   19.24 ± 2.70 
I36A    101.47 ± 22.72 
G37A    118.13 ± 22.11 
V38A      86.38 ± 12.73 
D39A      0.31 ± 0.07 
V40A    121.28 ± 23.82 
S45A       98.18 ± 24.30 
TMH2 Conserved in SG in TMH2 
G46A       99.59 ± 22.01 
R69A       0.10 ± 0.04 
TMH3 
RXXR motif previously identified as critical for 
function R72A       0.07 ± 0.02 
S112A      0.24 ± 0.09 
TMH3-4 
Periplasmic loop 
Conserved in periplasmic loop between TMH3-4 in 
AT3-SGNH fused proteins 
N113A      93.79 ± 14.92 
Y122A    85.76 ± 7.58 
G202A      74.14 ± 10.70 TMH6 Conserved trans membrane glycine 
E325A 
(Linker) 
     4.84 ± 1.13 
TMH10-11 
Cytoplasmic 
loop 
Conserved after TMH10 in all AT3-SGNH fused 
proteins 
Dark Grey= Point mutants with <1% O:5 signal intensity, Light Grey = Point mutants with <50% O:5 signal 
intensity, * = No OafA protein expression detected. Values represent the average of 2 biological repeats with 3 
technical replicates. 
  
 Table 2. Summary of site directed mutagenesis analysis of the periplasmic domain of OafA 
Mutant 
O:5 signal intensity compared to 
wild type % (± SEM) 
Reason for mutation 
C383,397S (Linker)
 
107.40 ± 26.80
 
Conserved disulphide bonding pairs
 
C439,453S
 
185.06 ± 54.63
 
C567,572S
 
49.98 ± 4.33
 
S437A
 
45.59 ± 3.42
 
Potential oxyanion hole residue 
 
E569A
 
99.87 ± 7.01
 
Conserved between most C-term Cys pair
 
S412A
 
0.36 ± 0.26
 
SGNH domain catalytic triad residues
 
D587A
 
10.13 ± 1.70
 
H590A
 
0.87 ± 0.62
 
Dark Grey= Point mutants with <1% O:5 signal intensity, Light Grey = Point mutants with <50% O:5 signal intensity. 
Values represent the average of 2 biological repeats with 3 technical replicates. 
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